Incidence of Malignancies in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Diagnosed Between 1991 and 2013.

about

Clinical trials in antineutrophil cytoplasmic antibody-associated vasculitis: what we have learnt so far, and what we still have to learn.Cancer in ANCA-Associated Glomerulonephritis: A Registry-Based Cohort Study.[S1 guidelines Diagnostics and treatment of ANCA-associated vasculitis].

P2860

Q39088103-13A133D5-03C7-4B9B-8731-C06F0667D8D9 Q48102349-A446EE6C-907F-40F8-A704-5578F00880AF Q50076914-B210F826-88BD-4F4C-B40D-7EFC4E8A4C1E

P2860

Incidence of Malignancies in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Diagnosed Between 1991 and 2013.

Item

http://www.wikidata.org/entity/Q38413238

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Incidence of Malignancies in P ...... agnosed Between 1991 and 2013.

@en

type

Item

label

Incidence of Malignancies in P ...... agnosed Between 1991 and 2013.

@en

prefLabel

Incidence of Malignancies in P ...... agnosed Between 1991 and 2013.

@en

P1476

Incidence of Malignancies in P ...... iagnosed Between 1991 and 2013

@en

P2093

Annelies E Berden

http://www.w3.org/2001/XMLSchema#string

Chinar Rahmattulla

http://www.w3.org/2001/XMLSchema#string

Ernst C Hagen

http://www.w3.org/2001/XMLSchema#string

Ingeborg M Bajema

http://www.w3.org/2001/XMLSchema#string

Jan A Bruijn

http://www.w3.org/2001/XMLSchema#string

Ron Wolterbeek

http://www.w3.org/2001/XMLSchema#string

Sophie-Charlotte Wakker

http://www.w3.org/2001/XMLSchema#string

P2860

Azathioprine and UVA light generate mutagenic oxidative DNA damage

2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides

Methods for analysing recurrent events in health care data. Examples from admissions in Ebeltoft Health Promotion Project.

Incidence of malignancy in patients treated for antineutrophil cytoplasm antibody-associated vasculitis: follow-up data from European Vasculitis Study Group clinical trials.

Efficacy of remission-induction regimens for ANCA-associated vasculitis.

Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years.

Diagnosis and management of ANCA associated vasculitis.

Solid malignancies among etanercept-treated patients with granulomatosis with polyangiitis (Wegener's): long-term followup of a multicenter longitudinal cohort.

Rituximab versus cyclophosphamide for ANCA-associated vasculitis.

Skin cancers after organ transplantation.

P304

3270-3278

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ART.39317

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Marlies E Reinders

P577

2015-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26246307

http://www.w3.org/2001/XMLSchema#string

Incidence of Malignancies in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Diagnosed Between 1991 and 2013.

about

P2860

P2860

Incidence of Malignancies in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Diagnosed Between 1991 and 2013.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698